TY - JOUR
T1 - Novel antimicrobial peptides and peptide-microbiome crosstalk in Appalachian salamander skin
AU - Muletz-Wolz, Carly
AU - Urrutia-Carter, Julian
AU - Osborne, Owen
AU - Kutos, Steve
AU - Meneses Montano, Jose
AU - Madison, Joseph
AU - Gratwicke, Brian
AU - Racharaks, Ratanachat
AU - Roncal, Norma
AU - Jiménez, Randall
AU - Ellison, Amy
AU - Cleland, Timothy
N1 - © 2025. The Author(s).
PY - 2025/11/20
Y1 - 2025/11/20
N2 - Using multi-omics tools, we discovered new antimicrobial peptides (AMPs) and examined AMP-microbial interactions in three Appalachian salamander species (Plethodon cinereus, Eurycea bislineata and Notophthalmus viridescens). We conducted skin transcriptomics (n = 13) and proteomics (n = 91) to identify 200+ candidate AMPs. With candidate AMPs, we identified correlations with skin microbiomes and synthesized 20 peptides to challenge against pathogens of amphibians (Batrachochytrium dendrobatidis: Bd) and humans (ESKAPEE). Using transcriptomics, candidate AMPs were detected in all individuals with Cathelidicins being most common. Using proteomics, AMPs were found in 34% of individuals (31/91)—predominately E. bislineata—with Kinin-like peptides being most common. Candidate AMP composition generally predicted skin bacterial composition, suggesting that AMPs influence host-microbial symbioses. Crude and synthesized peptides showed limited activity against Bd. Two synthesized Cathelicidins (Pcin-CATH3 and Pcin-CATH5) inhibited human pathogens, Acinetobacter baumannii, Pseudomonas aeruginosa and Escherichia coli. Our findings inform the potential usage of AMPs in conservation and translational applications.
AB - Using multi-omics tools, we discovered new antimicrobial peptides (AMPs) and examined AMP-microbial interactions in three Appalachian salamander species (Plethodon cinereus, Eurycea bislineata and Notophthalmus viridescens). We conducted skin transcriptomics (n = 13) and proteomics (n = 91) to identify 200+ candidate AMPs. With candidate AMPs, we identified correlations with skin microbiomes and synthesized 20 peptides to challenge against pathogens of amphibians (Batrachochytrium dendrobatidis: Bd) and humans (ESKAPEE). Using transcriptomics, candidate AMPs were detected in all individuals with Cathelidicins being most common. Using proteomics, AMPs were found in 34% of individuals (31/91)—predominately E. bislineata—with Kinin-like peptides being most common. Candidate AMP composition generally predicted skin bacterial composition, suggesting that AMPs influence host-microbial symbioses. Crude and synthesized peptides showed limited activity against Bd. Two synthesized Cathelicidins (Pcin-CATH3 and Pcin-CATH5) inhibited human pathogens, Acinetobacter baumannii, Pseudomonas aeruginosa and Escherichia coli. Our findings inform the potential usage of AMPs in conservation and translational applications.
KW - Animals
KW - Antimicrobial Cationic Peptides/pharmacology
KW - Antimicrobial Peptides/pharmacology
KW - Bacteria/drug effects
KW - Batrachochytrium/drug effects
KW - Caudata/microbiology
KW - Gene Expression Profiling
KW - Humans
KW - Microbiota
KW - Proteomics
KW - Skin/microbiology
KW - Antimicrobial Cationic Peptides
KW - Caudata
KW - Bacteria
KW - Skin
KW - Batrachochytrium
KW - Antimicrobial Peptides
U2 - 10.1038/s41522-025-00837-0
DO - 10.1038/s41522-025-00837-0
M3 - Article
C2 - 41266339
SN - 2055-5008
VL - 11
JO - NPJ Biofilms and Microbiomes
JF - NPJ Biofilms and Microbiomes
M1 - 213
ER -